Taylor Merry

Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with <i>in vivo</i> antiresorptive activity

William C. Shakespeare, Michael G. Yang, Regine S. Bohacek et al. · Proceedings of the National Academy of Sciences · 2000 · 133 citations · Full text

Medicinal Chemistry, Sclerostin, Biochemistry +15

Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70

Chi B. Vu, Evelyn G. Corpuz, Taylor Merry et al. · Journal of Medicinal Chemistry · 1999 · 88 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +15

Structure-activity relationships of a novel class of Src SH2 inhibitors

John L. Buchanan, Chi B. Vu, Taylor Merry et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 38 citations · Full text

Molecular Docking, Biochemistry, Medicine +8

X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor

Regine S. Bohacek, David C. Dalgarno, Marcos Hatada et al. · Journal of Medicinal Chemistry · 2001 · 37 citations · Full text

Crystal Structure, Drug Target, Src Sh2 Leads +21

Bone-Targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents

Chi B. Vu, George P. Luke, Noriyuki Kawahata et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 23 citations · Full text

Sclerostin, Medicine, Src Tyrosine Kinase +9